The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a flood of lower-priced alternatives , significantly diminishing its dominance. While certain firms may try to capitalize on male sexual dysfunction, the pre